Joerg-Thomas Regula

Title: Innovator Spotlight: Joerg-Thomas Regula

Introduction

Joerg-Thomas Regula is an innovative inventor based in Munich, Germany. With a strong background in biochemistry and immunology, he has made significant contributions to the field through his inventive methods and applications.

Latest Patents

Joerg-Thomas Regula holds three patents, among which his latest inventions are noteworthy:

1. **Method for determining the in vivo interaction mode**: This method describes how to ascertain the binding interaction of a multimeric antigen with human IgG1 subclass antibodies. The process involves determining binding affinities and analyzing results to differentiate between affinity-driven and avidity-driven interactions.

2. **Nucleic acid encoding dual Fc antigen binding proteins**: This invention relates to antigen binding proteins that possess two Fc parts. It encompasses their production methods, pharmaceutical compositions, and various applications.

Career Highlights

Regula is currently employed at Hoffmann-La Roche Inc., a leading pharmaceutical company renowned for its pioneering advancements in the healthcare sector. His tenure at Hoffmann-La Roche has enabled him to blend his research skills with practical applications in therapeutic development.

Collaborations

Throughout his career, Joerg-Thomas Regula has collaborated with talented colleagues, including Birgit Bossenmaier and Hubert Kettenberger. These partnerships have fostered a productive environment for innovation and have contributed to the successful advancement of various research projects.

Conclusion

Joerg-Thomas Regula is a prominent figure in the world of invention and innovation, with a particular focus on immunology and biotechnology. His latest patents reflect his dedication to advancing scientific knowledge and improving healthcare outcomes through innovative solutions.